Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-006001
Filing Date
2025-01-24
Accepted
2025-01-24 16:17:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm254230-1_s3.htm S-3 306044
2 EXHIBIT 5.1 tm254230d2_ex5-1.htm EX-5.1 10919
3 EXHIBIT 23.1 tm254230d2_ex23-1.htm EX-23.1 2203
4 EX-FILING FEES tm254230d2_ex-filingfees.htm EX-FILING FEES 23787
5 GRAPHIC tm254230d2_ex5-1img001.jpg GRAPHIC 2017
6 GRAPHIC tm254230d2_ex5-1img002.jpg GRAPHIC 7399
7 GRAPHIC lg_kalabio-4clr.jpg GRAPHIC 10008
  Complete submission text file 0001104659-25-006001.txt   371280
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284480 | Film No.: 25554438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)